Potent Weight Loss and Favorable Glycemic Control Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Models

被引：0
|
作者：
Park, Sang Hyun
Kim, Yohan
Kim, Jung Kuk
Lee, Dahae
Park, Eunjin
Kim, Jeong A.
Hong, Sunghee
Choi, Jaehyuk
Bae, Sungmin
Lee, Sang Hyun
Choi, In Young
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-776-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
776-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
    Bossart, Martin
    Wagner, Michael
    Elvert, Ralf
    Evers, Andreas
    Hubschle, Thomas
    Kloeckener, Tim
    Lorenz, Katrin
    Moessinger, Christine
    Eriksson, Olof
    Velikyan, Irina
    Pierrou, Stefan
    Johansson, Lars
    Dietert, Gabriele
    Dietz-Baum, Yasmin
    Kissner, Thomas
    Nowotny, Irene
    Einig, Christine
    Jan, Christelle
    Rharbaoui, Faiza
    Gassenhuber, Johann
    Prochnow, Hans-Peter
    Agueusop, Inoncent
    Porksen, Niels
    Smith, William B.
    Nitsche, Almut
    Konkar, Anish
    CELL METABOLISM, 2022, 34 (01) : 59 - +
  • [22] Anti-fibrotic potential of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in preclinical models of fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Lee, Seon Myeong
    Choi, Jae Hyuk
    Kwon, Hyunjoo
    Park, Enu Jin
    Bae, Sung Min
    Kim, Dae Jin
    Kim, Young Hoon
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2021, 75 : S614 - S614
  • [23] Anti-fibrotic potential of a novel long-acting glucagon/GIP/GLP-1 triple agonist (HM15211) in preclinical models of fibrosis
    Kim, J.
    Lee, J.
    Lee, S.
    Kwon, H.
    Park, E.
    Bae, S.
    Kim, D.
    Kim, Y.
    Choi, I.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 348 - 349
  • [24] ANTI-FIBROTIC POTENTIAL OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST, HM15211, IN PRECLINICAL MODELS OF FIBROSIS
    Kim, Jung Kuk
    Lee, Jong Suk
    Lee, Seon Myeong
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Bae, Sung Min
    Kim, Dae Jin
    Kim, Young Hoon
    Choi, In Young
    HEPATOLOGY, 2021, 74 : 1055A - 1056A
  • [25] Design of a novel long-acting dual GLP-1/GIP receptor agonist
    Dong, Yuanzhen
    Zhang, Jinhua
    Xu, Hongjiang
    Shen, Hengqiao
    Lu, Qin
    Feng, Jun
    Cai, Zhengyan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 100
  • [26] Multi-target engagement effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist (HM15211) in animal model of NASH
    Choi, J.
    Lee, J.
    Kim, J.
    Kwon, H.
    Park, E.
    Lee, J.
    Kim, D.
    Kim, Y.
    Choi, I.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 100 - 101
  • [27] Potent body weight loss, and therapeutic efficacy in a NASH animal model by a novel long-acting GLP-1/Glucagon/GIPtri-agonist (HM15211)
    Choi, I.
    Lee, J.
    Kim, J.
    Park, Y.
    Lee, S.
    Kim, Y.
    Kwon, S. -C.
    DIABETOLOGIA, 2017, 60 : S50 - S50
  • [28] Study on multi-target engagement effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in animal model of NASH
    Lee, Jong Suk
    Kim, Jung Kuk
    Lee, Seon Myeong
    Choi, Jae Hyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Lee, Jong Soo
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2021, 75 : S615 - S615
  • [29] Multi-target engagement effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in animal model of NASH/fibrosis
    Lee, Jong Suk
    Kim, Jung Kuk
    Lee, Seonmyeong
    Kim, Yohan
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2022, 77 : S468 - S469
  • [30] STUDY ON MULTI-TARGET ENGAGEMENT EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST, HM15211, IN ANIMAL MODEL OF NASH
    Lee, Jong Suk
    Kim, Jung Kuk
    Lee, Seon Myeong
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Lee, Jong Soo
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2021, 74 : 1088A - 1089A
12345